Drug Interaction Report

Patients that have been treated with allogeneic processed thymus tissue should let their doctor know before receiving influenza virus vaccine, H1N1, live. Allogeneic processed thymus tissue is intended to help the body develop a part of the immune system called T cells, which are important to help the body fight infections. Depending on the length of time since the patient has been treated with allogeneic processed thymus tissue, their body may not have had enough time to develop this part of their immune system. The patient may therefore be at risk for developing an infection from influenza virus vaccine, H1N1, live or have a reduced response to it. In some situations, the doctor may want to delay administering influenza virus vaccine, H1N1, live until the patient's immune system is improved. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.